Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Carruthers

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Pharmacoepidemiology and Drug Safety|May 24, 2016
Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progressionTingting Zhang, Elaine Kingwell, Hilda Ji De Jong, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
Phenome-wide examination of comorbidity burden and multiple sclerosis disease severityTingting Zhang, Matthew Goodman, Feng Zhu, et al.
Science (New York, N.Y.)|November 25, 2003
Diverse psychotomimetics act through a common signaling pathwayPer Svenningsson, Eleni T Tzavara, Robert Carruthers, et al.
Neuroimage. Clinical|July 21, 2017
Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorderAnna J E Combes, Lucy Matthews, Jimmy S Lee, et al.
Neurology|January 5, 2018
Effects of physical comorbidities on disability progression in multiple sclerosisTingting Zhang, Helen Tremlett, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders|October 7, 2023
A Canadian case control study investigating demographic and environmental factors associated with MOGADSam Hosseini-Moghaddam, Ruth Ann Marrie, Christina Wolfson, et al.
Neuroimage. Clinical|June 23, 2016
Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis opticaPraveena Manogaran, Irene M Vavasour, Alex P Lange, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 12, 2020
Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis PatientsJillian K Chan, Elena Hernandez Martínez de Lapiscina, Carolyn Taylor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2023
A national case-control study investigating demographic and environmental factors associated with NMOSDDalia L Rotstein, Christina Wolfson, Robert Carruthers, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 5, 2025
A broad range of antiphospholipid IgM are elevated across different multiple sclerosis clinical phenotypesKaya Frese, Pal Patel, Pierre Becquart, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Pharmacoepidemiology and Drug Safety|May 24, 2016
Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progressionTingting Zhang, Elaine Kingwell, Hilda Ji De Jong, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
Phenome-wide examination of comorbidity burden and multiple sclerosis disease severityTingting Zhang, Matthew Goodman, Feng Zhu, et al.
Science (New York, N.Y.)|November 25, 2003
Diverse psychotomimetics act through a common signaling pathwayPer Svenningsson, Eleni T Tzavara, Robert Carruthers, et al.
Neuroimage. Clinical|July 21, 2017
Cervical cord myelin water imaging shows degenerative changes over one year in multiple sclerosis but not neuromyelitis optica spectrum disorderAnna J E Combes, Lucy Matthews, Jimmy S Lee, et al.
Neurology|January 5, 2018
Effects of physical comorbidities on disability progression in multiple sclerosisTingting Zhang, Helen Tremlett, Feng Zhu, et al.
Multiple Sclerosis and Related Disorders|October 7, 2023
A Canadian case control study investigating demographic and environmental factors associated with MOGADSam Hosseini-Moghaddam, Ruth Ann Marrie, Christina Wolfson, et al.
Neuroimage. Clinical|June 23, 2016
Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis opticaPraveena Manogaran, Irene M Vavasour, Alex P Lange, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 12, 2020
Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis PatientsJillian K Chan, Elena Hernandez Martínez de Lapiscina, Carolyn Taylor, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2023
A national case-control study investigating demographic and environmental factors associated with NMOSDDalia L Rotstein, Christina Wolfson, Robert Carruthers, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 5, 2025
A broad range of antiphospholipid IgM are elevated across different multiple sclerosis clinical phenotypesKaya Frese, Pal Patel, Pierre Becquart, et al.
Pageof 6